Compositions and methods for producing elevated and sustained ketosis
Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol/L), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. Use of these substances does not adversely affect lipid profiles. By initiating rapid ketosis and accelerating the rate of ketoadaptation, this invention is useful for the avoidance of glucose withdrawal symptoms commonly experienced by individuals initiating a ketogenic diet, and minimizes the loss of lean body mass during dietary restriction.
1. A composition, comprising:
at least one medium chain fatty acid or ester thereof in an amount between about 5 grams and about 50 grams; and
at least one beta-hydroxybutyrate compound in an amount between about 2 grams and about 50 grams, wherein the at least one beta-hydroxybutyrate compound is comprised of a beta-hydroxybutyrate salt.
2. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound comprises one or more of a beta-hydroxybutyrate salt comprising sodium beta-hydroxybutyrate, arginine beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, magnesium beta-hydroxybutyrate, lithium beta-hydroxybutyrate, lysine beta-hydroxybutyrate, histidine beta-hydroxybutyrate, omithine beta-hydroxybutyrate, creatine beta-hydroxybutyrate, agmatine beta-hydroxybutyrate, or citrulline beta-hydroxybutyrate.
3. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.
4. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is comprised of (i) a beta-hydroxybutyrate salt and 1,3-butanediol, (ii) a beta-hydroxybutyrate salt and ethyl acetoacetate, (iii) a beta-hydroxybutyrate salt and ethyl beta-hydroxybutyrate, (iv) a salt mixture of beta-hydroxybutyrate salts and 1,3-butanediol, (v) a salt mixture of beta-hydroxybutyrate salts and ethyl acetoacetate, or (vi) a salt mixture of beta-hydroxybutyrate salts and ethyl beta-hydroxybutyrate.
5. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is racemic DL-beta-hydroxybutyrate or the single isomer R-beta-hydroxybutyrate.
6. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams.
7. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams.
8. The composition of claim 1 , wherein the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
9. The composition of claim 1 , wherein the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
10. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
11. The composition of claim 1 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
12. The composition of claim 1 , wherein the at least one medium chain fatty acid or ester thereof is selected from the group consisting of medium chain triglycerides, coconut oil, coconut milk powder, fractionated coconut oil, palm kernel oil, isolated hexanoic acid, isolated octanoic acid, isolated decanoic acid, ethoxylated triglyceride, enone triglyceride derivatives thereof, aldehyde triglyceride derivatives thereof, monoglyceride derivatives thereof, diglyceride derivatives thereof, triglyceride derivatives thereof, or an alkyl ester thereof.
13. The composition of claim 1 , further comprising at least one additional component selected from the group consisting of amino acids, amino acid metabolites, vitamins, minerals, coconut milk powder, electrolytes, NADH, tetrahydrobiopeterin, alpha-ketoglutaric acid, alpha lipoic acid, nutritional co-factors, calcium beta-methyl-beta-hydroxybutyrate, arginine alpha-ketoglutarate, sodium R-alpha lipoic acid, thiamine, riboflavin, niacin, pyridoxine, ascorbic acid, citric acid, malic acid, sodium benzoate, potassium sorbate, acesulfame K, aspartame, xanthan gum, and combinations thereof.
14. The composition of claim 11 , further comprising at least one additional component selected from the group consisting of amino acids, amino acid metabolites, vitamins, minerals, coconut milk powder, electrolytes, NADH, tetrahydrobiopeterin, alpha-ketoglutaric acid, alpha lipoic acid, nutritional co-factors, calcium beta-methyl-beta-hydroxybutyrate, arginine alpha-ketoglutarate, sodium R-alpha lipoic acid, thiamine, riboflavin, niacin, pyridoxine, ascorbic acid, citric acid, malic acid, sodium benzoate, potassium sorbate, acesulfame K, aspartame, xanthan gum, and combinations thereof.
15. The composition of claim 14 , wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.
16. The composition of claim 1 , wherein the at least one medium chain fatty acid or ester thereof and the at least one beta-hydroxybutyrate compound are each included in an effective amount so as to induce ketosis in a mammal for at least 240 minutes.
17. A composition for inducing sustained ketosis in a mammal, comprising:
at least one medium chain fatty acid or ester thereof; and
at least one beta-hydroxybutyrate compound, wherein the at least one beta-hydroxybutyrate compound is comprised of a beta-hydroxybutyrate salt,
wherein the at least one medium chain fatty acid or ester thereof and the at least one beta-hydroxybutyrate compound are included in an effective amount so as to induce ketosis in a mammal for at least 240 minutes.
18. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams.
19. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams.
20. The composition of claim 17 , wherein the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
21. The composition of claim 17 , wherein the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
22. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
23. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
24. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound comprises one or more of a beta-hydroxybutyrate salt comprising sodium beta-hydroxybutyrate, arginine beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, magnesium beta-hydroxybutyrate, lithium beta-hydroxybutyrate, lysine beta-hydroxybutyrate, histidine beta-hydroxybutyrate, omithine beta-hydroxybutyrate, creatine beta-hydroxybutyrate, agmatine beta-hydroxybutyrate, or citrulline beta-hydroxybutyrate.
25. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.
26. The composition of claim 17 , wherein the at least one beta-hydroxybutyrate compound is comprised of (i) a beta-hydroxybutyrate salt and 1,3-butanediol, (ii) a beta-hydroxybutyrate salt and ethyl acetoacetate, (iii) a beta-hydroxybutyrate salt and ethyl beta-hydroxybutyrate, (iv) a salt mixture of beta-hydroxybutyrate salts and 1,3-butanediol, (v) a salt mixture of beta-hydroxybutyrate salts and ethyl acetoacetate, or (vi) a salt mixture of beta-hydroxybutyrate salts and ethyl beta-hydroxybutyrate.
27. The composition of claim 17 , wherein the at least one medium chain fatty acid or ester thereof is selected from the group consisting of medium chain triglycerides, coconut oil, coconut milk powder, fractionated coconut oil, palm kernel oil, isolated hexanoic acid, isolated octanoic acid, isolated decanoic acid, ethoxylated triglyceride, enone triglyceride derivatives thereof, aldehyde triglyceride derivatives thereof, monoglyceride derivatives thereof, diglyceride derivatives thereof, triglyceride derivatives thereof, or an alkyl ester thereof.
28. The composition of claim 17 , further comprising at least one additional component selected from the group consisting of amino acids, amino acid metabolites, vitamins, minerals, coconut milk powder, electrolytes, NADH, tetrahydrobiopeterin, alpha-ketoglutaric acid, alpha lipoic acid, nutritional co-factors, calcium beta-methyl-beta-hydroxybutyrate, arginine alpha-ketoglutarate, sodium R-alpha lipoic acid, thiamine, riboflavin, niacin, pyridoxine, ascorbic acid, citric acid, malic acid, sodium benzoate, potassium sorbate, acesulfame K, aspartame, xanthan gum, and combinations thereof.
29. A method of promoting or sustaining ketosis in a mammal, comprising:
administering the composition of claim 1 to a mammal to promote or sustain ketosis.
30. The method of claim 29 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
31. The method of claim 29 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
32. The method of claim 29 , wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.
33. The method of claim 29 , wherein the at least one medium chain fatty acid or ester thereof is selected from the group consisting of medium chain triglycerides, coconut oil, coconut milk powder, fractionated coconut oil, palm kernel oil, isolated hexanoic acid, isolated octanoic acid, isolated decanoic acid, ethoxylated triglyceride, enone triglyceride derivatives thereof, aldehyde triglyceride derivatives thereof, monoglyceride derivatives thereof, diglyceride derivatives thereof, triglyceride derivatives thereof, or an alkyl ester thereof.
34. The method of claim 29 , wherein the composition further comprises at least one additional component selected from the group consisting of amino acids, amino acid metabolites, vitamins, minerals, coconut milk powder, electrolytes, NADH, tetrahydrobiopeterin, alpha-ketoglutaric acid, alpha lipoic acid, nutritional co-factors, calcium beta-methyl-beta-hydroxybutyrate, arginine alpha-ketoglutarate, sodium R-alpha lipoic acid, thiamine, riboflavin, niacin, pyridoxine, ascorbic acid, citric acid, malic acid, sodium benzoate, potassium sorbate, acesulfame K, aspartame, xanthan gum, and combinations thereof.
35. The method of claim 29 , wherein the composition is administered at least once a day for between one and two weeks, and wherein the method further comprises the mammal restricting intake of carbohydrates and protein.
36. A method of suppressing appetite or promoting weight loss in a mammal, comprising
administering the composition of claim 1 to a mammal to promote or sustain ketosis.
37. The method of claim 36 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 5 grams and about 30 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 10 grams and about 40 grams.
38. The method of claim 36 , wherein the at least one beta-hydroxybutyrate compound is included in an amount between about 10 grams and about 20 grams and the at least one medium chain triglyceride or ester thereof is included in an amount between about 15 grams and about 30 grams.
39. The method of claim 36 , wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.
40. The method of claim 36 , wherein the at least one medium chain fatty acid or ester thereof is selected from the group consisting of medium chain triglycerides, coconut oil, coconut milk powder, fractionated coconut oil, palm kernel oil, isolated hexanoic acid, isolated octanoic acid, isolated decanoic acid, ethoxylated triglyceride, enone triglyceride derivatives thereof, aldehyde triglyceride derivatives thereof, monoglyceride derivatives thereof, diglyceride derivatives thereof, triglyceride derivatives thereof, or an alkyl ester thereof.
41. The method of claim 36 , wherein the composition further comprises at least one additional component selected from the group consisting of amino acids, amino acid metabolites, vitamins, minerals, coconut milk powder, electrolytes, NADH, tetrahydrobiopeterin, alpha-ketoglutaric acid, alpha lipoic acid, nutritional co-factors, calcium beta-methyl-beta-hydroxybutyrate, arginine alpha-ketoglutarate, sodium R-alpha lipoic acid, thiamine, riboflavin, niacin, pyridoxine, ascorbic acid, citric acid, malic acid, sodium benzoate, potassium sorbate, acesulfame K, aspartame, xanthan gum, and combinations thereof.
42. The method of claim 36 , wherein the composition is administered at least once a day for between one and two weeks, and wherein the method further comprises the mammal restricting intake of carbohydrates and protein.
43. A composition, comprising:
a medium chain fatty acid or ester thereof in an amount between about 15 grams and about 30 grams, the medium chain fatty acid or ester thereof consisting of a medium chain triglyceride; and
at least one beta-hydroxybutyrate compound in an amount between about 10 grams and about 20 grams, wherein the at least one beta-hydroxybutyrate compound comprises a salt mixture comprising a plurality of sodium beta-hydroxybutyrate, potassium beta-hydroxybutyrate, calcium beta-hydroxybutyrate, or magnesium beta-hydroxybutyrate.